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ORIGINAL ARTICLE

3D-printed Biomimetic Bioactive Glass Scaffolds for
Bone Regeneration in Rat Calvarial Defects
Krishna C. R. Kolan1*, Yue-Wern Huang2, Julie A. Semon2, Ming C. Leu1
Department of Mechanical and Aerospace Engineering, Missouri University of Science and Technology, Rolla, Missouri,
USA
2
Department of Biological Sciences, Missouri University of Science and Technology, Rolla, Missouri, USA
1

Abstract: The pore geometry of scaffold intended for the use in the bone repair or replacement is one of the most important
parameters in bone tissue engineering. It affects not only the mechanical properties of the scaffold but also the amount of
bone regeneration after implantation. Scaffolds with five different architectures (cubic, spherical, x, gyroid, and diamond)
at different porosities were fabricated with bioactive borate glass using the selective laser sintering (SLS) process. The
compressive strength of scaffolds with porosities ranging from 60% to 30% varied from 1.7 to 15.5 MPa. The scaffold’s
compressive strength decreased significantly (up to 90%) after 1-week immersion in simulated body fluids. Degradation of
scaffolds is dependent on porosity, in which the scaffold with the largest surface area has the largest reduction in strength.
Scaffolds with traditional cubic architecture and biomimetic diamond architecture were implanted in 4.6 mm diameter fullthickness rat calvarial defects for 6 weeks to evaluate the bone regeneration with or without bone morphogenetic protein
2 (BMP-2). Histological analysis indicated no significant difference in bone formation in the defects treated with the two
different architectures. However, the defects treated with the diamond architecture scaffolds had more fibrous tissue formation
and thus have the potential for faster bone formation. Overall, the results indicated that borate glass scaffolds fabricated using
the SLS process have the potential for bone repair and the addition of BMP-2 significantly improves bone regeneration.
Keywords: Selective laser sintering, Bioactive borate glass, In vivo bone formation, Porosity, Pore geometry, Scaffold
architecture
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1 Introduction
Since the discovery of Bioglass® by Dr. Hench
in 1969, researchers have identified a wide range
of glass and glass-ceramic compositions for bone
repair as well as soft tissue applications[1-3]. The
advantage of utilizing silicate-based bioactive
glasses for bone repair is their conversion
to hydroxyapatite (HA), the main mineral
constituent of bone, that can readily integrate with
surrounding tissue[2]. The research on bioactive
glasses has evolved from traditional SiO2

networks to highly resorbable glass compositions
based on B2O3 networks as researchers have
focused on developing borate and borophosphate
glasses for biological applications due to the
ability to support angiogenesis and offer faster
degradation[4]. Several studies have investigated
gradual replacement of SiO2 in silicate glass with
B2O3 and reported the effects of glass dissolution,
tissue infiltration, and cell culture compatibility
of the borosilicate glasses[5,6]. Borate glass is
chemically less durable in comparison to silicate
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License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the
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glass and consequently, it degrades at a faster rate
which allows quick release of calcium, boron, and
other ionic dissolution products and provides rapid
HA formation[7]. Hence, in this study, biomimetic
borate glass scaffolds for bone regeneration in rat
calvarial defects were fabricated and characterized
in terms of material composition, porosity,
architecture, and mechanical properties.
Among different additive manufacturing
(AM) techniques, the powder bed fusion and
vat photopolymerization techniques enable
the fabrication of complex lattice structures
mimicking natural bone architectures, which
is much more difficult to achieve with material
extrusion techniques[8-10]. Thus, laser powder bed
fusion processes like selective laser sintering
(SLS) can be used to create scaffolds with
different architectures to study the effects of pore
shape on the mechanical properties of scaffolds
and their associated bone regenerative capacity.
Several methods were proposed to create scaffold
CAD models that possess a gradient of porosity,
conformity, and architectures that closely mimic
human trabecular bone[11-16]. Several challenges
exist in the powder bed fusion-based 3D printing
of ceramic/glass scaffolds with complex pores of
size ranging from 100 to 600 µm because of the
ceramic/glass material properties and sintering
requirements[17]. In the recent past, there has been
interested in the fabrication of ceramic and glass
structures using the selective laser melting process
with the help of high-temperature preheating of
substrate[18-20]. Nevertheless, an indirect method
that involves additional post-processing after green
part fabrication allows for controlled structural
densification avoiding glass crystallization[21,22].
Unlike metallic scaffolds, bioactive glass scaffolds
degrade upon implantation in vivo or after soaking
in simulated body fluids (SBF), thereby affecting
their structural integrity. Factors that influence
this outcome include, but are not limited to,
bioactive glass composition, scaffold porosity,
and pore geometry (which affects surface area for
reaction). Therefore, investigating the effect of
porosity and pore geometry on the degradation of
scaffolds made with bioresorbable materials, such
as bioactive glasses, could help design implants to

repair diverse regions of the skeletal system with
different structural and biological requirements.
The effect of scaffold architecture on
mechanical properties, cell proliferation, and bone
regeneration has been investigated using polymer
and metallic scaffolds[23-26]. There are inconclusive
reports on the influence of pore size on bone
regeneration. While some reports suggested pore
sizes in the range of 100 – 300 µm are beneficial
for bone growth, other studies demonstrated
increase bone tissue growth with pores >300 µm
and up to 800 µm[27,28]. Some of these studies were
performed using bioceramic scaffolds and others
were performed on biopolymer and metallic
(titanium-based) scaffolds that do not degrade
like bioactive glass. Bone repair using scaffolds
made from resorbable materials such as bioactive
glasses is likely to have distinct characteristics as
the scaffold properties change post-implantation
in the dynamic in vivo environment. For example,
silicate-based glasses degrade slowly even in
vivo because of the chemical stability of the SiO2
network. A recent in vivo evaluation of silicatebased glass scaffolds showed that about half of the
scaffold (unconverted glass) still remained in the
defect region after 6 months[29]. However, borate
glass fibers used to treat a calvarial defect were
reported to degrade more quickly, with most of the
glass converted to HA and resulting in better bone
regeneration in comparison to silicate glasses[30].
The scaffold architecture could also play
an important role in in vitro cell proliferation,
differentiation, and bone regeneration, with
some studies suggesting pore curvature driven
tissue growth[24,31-33]. Although these in vitro
observations were, in general, in agreement with
theoretical predictions, the influence of curvature
on tissue regeneration has not been demonstrated
in vivo. Pore geometry, pore size, and porosity are
interrelated. Importantly, the resorbable nature
of borate glass could further complicate the
mechanism of the bone regeneration process in
vivo, relative to more predictable bone formation
in metallic, or biopolymer scaffolds.
In the present study, we hypothesized that a
borate glass scaffold with biomimetic architecture
would have sufficient strength and stiffness for

International Journal of Bioprinting (2020)–Volume 6, Issue 2

83



3D-printed borate glass scaffolds for bone repair

non-loading bone repair and increase the bone
regeneration in a critical-sized bone defect. To test
this hypothesis, we compared the structural and
mechanical properties of the borate glass scaffolds
with five different architectures, namely, cubic,
spherical, x, gyroid, and diamond. Degradation
of scaffolds in SBF was assessed. Subsequently,
cubic and diamond architecture scaffolds were
chosen to evaluate the bone regeneration in a
rat calvarial defect model. Cubic architecture
represented a traditional lattice design whereas
diamond architecture represented a biomimetic
architecture that mimics natural bone, which
has previously been shown to promote cell
proliferation in vitro[34]. The treatment groups
included borate glass scaffolds with or without
bone morphogenetic protein-2 (BMP-2), an
established osteogenesis inducing protein in this
study.
2 Materials and methods
2.1 Scaffold fabrication
Bioactive borate glass (13-93B3 glass; nominal
composition in wt % – 56.6% B2O3, 5.5% Na2O,
11.1% K2O, 4.6% MgO, 18.5% CaO, 3.7% P2O5)
with an average particle size of ~12 µm was used
in this research. Borate glass particles were mixed
with a polymeric binder and then dry ball-milled to
obtain the feedstock powder for the SLS machine
(DTM Sinterstation 2000). The binder content,
feedstock preparation, and scaffold fabrication
parameters established previously for silicate glass
(laser power – 5 W, scan speed – 508 mm/s, scan
spacing – 0.23 mm, layer thickness – 76.2 µm,
15 wt % binder) were adopted in this study[35].
The fabricated parts were heat treated in a furnace
(Vulcan Benchtop, York, PA) to remove the
polymeric binder and sintered at 570°C for 1 h.
2.2 Scaffold assessment
Scaffolds measuring 5 × 5 × 5 mm3 were used
for compression tests and scaffolds measuring
10 × 10 × 10 mm3 were used to measure porosity
using Archimedes method. The scaffold’s pore
size was measured using an optical microscope.
84

A cross-head speed of 0.5 mm/min was used
during the compression tests with a mechanical
load frame (Instron 4469, Norwood, MA). Five
samples in each set were used and the average
values were reported with standard deviation.
X-ray diffraction (XRD) analysis (Philips X-Pert,
Westborough, MA) was performed on the asreceived borate glass powder, sintered scaffolds,
as well as the dried scaffolds after soaking in the
SBF to confirm the crystalline-like formations
on the scaffold surface, the amorphous nature
of borate glass, and its conversion. Scanning
electron microscopy (SEM) (S-570, Hitachi Co.,
Tokyo, Japan) was used to analyze the surface
morphology of the scaffold.
2.3 Degradation tests
An established protocol was used to prepare the SBF
solution[36]. Samples were ultrasonically cleaned
3 times using ethanol and then dried in an oven
overnight before kept in the SBF solution (100 ml
of solution was used for 1 g of the scaffold). The
scaffolds were soaked in an incubator maintained
at 37°C. To evaluate the scaffold degradation,
compression tests were conducted on soaked
scaffolds in their wet condition. At least three
samples in each set were used and the average
values with standard deviations were reported.
2.4 Scaffold preparation before implantation
For in vivo tests, cubic and diamond scaffolds were
grinded to the required dimensions (~1.5 mm thick
disks having 4.6 mm in diameter), ultrasonically
washed thrice (5 min each) with ethanol, dried in
air and then heat sterilized overnight at 250°C. Six
animals were used for each treatment group and
scaffolds with ~50% porosity were used for this
study. Experiments were carried out with or without
the use of BMP-2. Animals were randomized to
different types of scaffold, based on the presence
or absence of BMP-2. Scaffolds were soaked in
SBF for 6 h and then dried at room temperature
overnight before loading BMP-2 to roughen the
surface for improved protein adhesion. BMP-2
was dissolved in citric acid (10 µg in 100 µl) and
10 µl of the solution was loaded on each scaffold
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(equivalent of 1 µg per scaffold). Scaffolds were
kept in the refrigerator overnight for protein
adhesion before implantation. The adhesion and
release of BMP-2 from borate glass scaffolds were
assumed to be similar to the release of bovine
serum albumin (BSA) from borate glass scaffolds
fabricated using the SLS process. Therefore, the
protocol of loading BMP-2 was developed based
on the release of BSA from borate glass scaffolds
that occurred over a period of 4 days. Table 1
shows the experimental plan of scaffold placement
in Sprague Dawley rats.
2.5 Surgical procedure
Animal care and use were approved by the
Missouri S&T Institutional Animal Care and Use
Committee. Twelve 12-week-old male Sprague
Dawley rats (~350 g in body weight) were
anesthetized with a 0.6 ml ketamine/xylazine
(200 mg ketamine and 20 mg xylazine per 4 ml)
abdominal injection. A full-thickness defect
measuring 4.6 mm in diameter was created in the
central area of each parietal bone using a hand
drill and trephine bur (ACE Surgical Supply Co.
Inc., Brockton, MA) under constant irrigation
with saline solution without disturbing the dura
mater. AutoClip® wound closing system (Braintree
Scientific, Inc., Braintree, MA) was used for site
closure and animals were given 0.2 ml of penicillin
subcutaneously and ketoprofen (3 mg/kg body
weight) intramuscularly post-surgery. After
6 weeks, animals were euthanized by means of
CO2 inhalation and samples from defect sites with
surrounding bone were harvested for subsequent
examination.
2.6 Histological processing
The harvested samples were fixed in 10% buffered
formaldehyde for ~3 days, soaked in DI water
overnight, and bisected in half. Samples were
decalcified in Cal-Ex II simultaneous Fixative/
Decalcifier (Fisher Scientific, Pittsburgh, PA)
solution by changing the solution every 2 days
during the 1st week and then once every 4 days
for about ~4 weeks. The samples were dehydrated
with a series of ethanol solutions by a microwave

Table 1. Borate glass scaffold placement in rat
calvarial defects.
Without BMP-2
Animal #
1
2
3
4
5
6

Left
side
D
D
D
C
C
C

C: Cubic; D: Diamond.

With BMP-2
Right
side
D
D
C
D
C
C

Animal #
7
8
9
10
11
12

Left
side
D
D
D
C
C
C

Right
side
D
D
C
D
C
C

dehydration technique (EBSciences H2850
Microwave Processor). Briefly, the sample
temperature was set to ~37°C and the samples
were heated for about 2.5 min in the microwave
followed by 12.5 min of idle time. The samples
were then soaked in xylene solution followed
by paraffin mounting at 45°C using a paraffin
mounting system (Leica EG 1150H, Buffalo
Grove, IL). Specimens were cut at 5 µm thin
sections and mounted on glass slides. Slides were
stained with hematoxylin and eosin (H&E) and
Masson’s trichrome to determine the amount of
new bone tissue and fibrous tissue. Optical images
of stained sections were taken with an Olympus
BX 50 microscope.
2.7 Histomorphometric analysis
Histomorphometric analysis was carried out using
the stitched optical images (with Microsoft Image
Composite Editor software) of the stained sections
and ImageJ software[37]. The percentage of new bone
formed in defects was evaluated from the optical
images. The total defect area was defined as the
region between the two boundaries formed during
the drilling process. The remaining scaffold and the
tissue within were identified. The newly formed bone
was outlined and measured within the defect area
and expressed as a percentage of the total defect area.
The measurements were blinded and performed by
persons with no knowledge of the treatment groups.
2.8 Statistical analysis
The data were reported as the mean ± standard
deviation. Analysis of differences in means was
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performed using a one-way analysis of variance
with Tukey’s post hoc test. The statistical
significance was set at P < 0.05.
3 Results and discussion
3.1 Fabrication and structural assessment
CAD models of scaffolds with five different
architectures and their unit cells are shown
in Figure 1A. The porosity of cubic and X
architectures is a function of the size of the unit
cell and the diameter of the struts. In the case of
spherical architecture, the porosity is a function of
the diameter of the sphere subtracted from a unit
cube. These three architectures represent the most
commonly used scaffold designs for bone tissue
engineering fabricated by AM techniques. The
diamond and gyroid architectures were designed to
create surfaces with constant mean curvature and
to mimic natural trabecular bone architecture[38].
These surfaces were generated using opensource software called K3DSurf (http://k3dsurf.
sourceforge.net/) and were converted to CAD files
for fabrication (Figure 1A). The representative
optical microscope images of scaffolds with
A

varying porosities are shown in Figure 1B.
Figure 1C shows representative scaffolds of each
architecture and Figure 1D shows the diamond
architecture scaffolds with different porosities.
Scaffolds were designed to have 50%, 60%,
70%, and 80% volumetric porosity but the measured
apparent porosities (Table 2) were lower than the
designed values. The overall deviation between
designed and apparent porosities was ~19% for
spherical, diamond, gyroid scaffolds, ~17% for
cubic scaffolds, and ~25% for X scaffolds. The
difference between the designed and apparent
porosity was the most for X scaffolds and the least
for cubic scaffolds. This was due to the powder
particles getting stuck inside the pores during the
excess powder removal from the “green body”
(SLS fabricated part before post-processing).
These powder particles were sintered during heat
treatment, thereby reducing the overall porosity. It
is recommended that this effect and the resulting
difference in porosity be accounted in the designs
before scaffold fabrication using the SLS process.
The adhered powder particles in the green body
also affected the overall scaffold pore sizes, shown
in Table 2. Overall, scaffold pore sizes varied
C

B
D

Figure 1. (A) Unit cells and scaffold architectures: Cubic, spherical, X, gyroid, and diamond,
(B) representative optical images of 5 × 5 × 5 mm3 borate glass scaffolds with corresponding architectures
at three different porosities used for compression tests, (C) representative scaffold of each architecture
measuring 10 × 10 × 10 mm3 used to measure porosity, and (D) 10 × 10 × 10 mm3 diamond architecture
scaffolds at four different porosities (34% – 61%).
86
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Table 2. Scaffold porosity and pore size.
Architecture
Cubic
Spherical
X
Diamond
Gyroid

Designed versus apparent (%)
50
33±2
32±1
28±2
34±2
34±1

60
40±2
42±3
35±3
40±1
41±1

70
54±1
49±3
43±2
47±1
49±1

80
66±3
61±1
55±0
61±1
60±1

between 0.5 and 1.3 mm. X architecture scaffolds
had the smallest pores which are consistent with
the X scaffolds having the largest difference
between the designed and apparent porosities.
The difficulty in removing adhered powder from
the X scaffold pores of green bodies contributed
to its lowest porosity and most reduced pore size.
The average pore size of scaffolds designed with
80% porosity ranged from 0.9 mm to 1.3 mm, and
the scaffolds designed with 50% porosity ranged
from 0.5 mm to 0.8 mm. In theory, unit cell pore
size varies along the Z-height, with it being the
smallest at the end and the largest at the center of
the unit cell. Therefore, true scaffold pore size has
a range of values instead of being a constant value.
Several parameters limit the accuracy
of fabricating scaffolds, including scaffold
architecture, the resolution of the machine, layer
thickness, binder content, and particle size. The
laser spot diameter of the SLS machine was
0.45 mm and therefore, it was not feasible to
fabricate scaffolds with struts smaller than this
limit (<0.45 mm). The laser spot could have
heated and melted particles adjacent to the
scanning area, effectively reducing the designed
pore size. Smaller particles are easier to remove
from the green body scaffold pores, causing
less deviation from the actual design. However,
smaller particles require higher binder content
because of the increased surface area that could
increase the shrinkage and deviations between
designed and fabricated parts. The amount of
binder and the particle size was optimized for
scaffold fabrication in our previous work[35].
One key aspect in designing the architecture
was considering scaffold manufacturability.
For instance, in spherical scaffolds, porosity is
a function of the diameter of the sphere that is

Measured average pore size (µm)
50
0.5±0.02
0.5±0.04
0.5±0.03
0.8±0.01
0.8±0.01

60
0.7±0.02
0.6±0.05
0.6±0.02
0.9±0.01
0.9±0.01

70
1.0±0.04
1.0±0.04
0.7±0.03
1.0±0.04
1.0±0.03

80
1.3±0.02
1.0±0.04
1.2±0.10
1.2±0.05
1.1±0.04

subtracted from the solid unit cube to obtain the
unit cell of spherical architecture. Figure 2A
shows unit cells of spherical and cubic scaffolds
and their pore shapes and pore sizes. Decreasing
sphere diameter to lower porosity would hinder
the removal of powder particles from the scaffold.
Hence, unit cell pores were designed to enable
fabrication and removal of powder particles. The
pore volume variation for cubic and spherical unit
cells is shown in Figure 2B.
3.2 Effect of porosity and pore geometry on
mechanical strength
Compressive strengths of borate glass scaffolds
with different porosities are shown in Figure 3A.
Among the five architectures investigated in this
study, cubic scaffolds had the highest compressive
strength (15.5 ± 1.9 MPa) and X scaffolds had the
lowest strength (4.9 ± 1.2 MPa) at low porosity
(~35%). The biomimetic architectures (gyroid and
diamond scaffolds) had compressive strengths of
9.5 ± 2.5 MPa and 6.8 ± 1.6 MPa, respectively.
The scaffold compressive strengths at low
porosity were near the high end of the range of
compressive strength for human trabecular bone
(~2 – ~12 MPa), whereas the strengths at high
porosity levels (>55%) were near the low end of
the spectrum[39]. Cubic architecture scaffolds have
pillars in the axial direction that carry a majority
of the load in compression tests before structural
failure, while the other architectures lacked a
similar feature. X architecture scaffolds provided
the least resistance in compression because of
the 45° oriented struts. The compressive strength
for all scaffold types was ~4 MPa or less at
high porosities, which falls at the lower range
of the trabecular bone compressive strength[39].
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A

B

Figure 2. (A) Unit cells and pore shapes of cubic and spherical architecture scaffolds, (B) pore volume
variation of spherical and cubic scaffolds with porosity. Cylindrical extensions to the spherical pores
were designed to maintain sufficient pore size for powder removal from the scaffold.
Overall, the differences in scaffold compressive
strength at higher porosities (>55%) were not
as significant as they were at lower porosities
(<35%). Architecture of scaffold contributes to
cell proliferation, tissue growth, and scaffold
structural integrity. Therefore, it is crucial to
optimize the porosity and architecture of a
scaffold, depending on the application. Another
important aspect of the scaffold structural integrity
is the elastic modulus during compression which
measures the scaffold stiffness. Scaffolds with
higher stiffness are not desired in load-bearing
applications as they are known to cause stress
shielding effect. However, as borate glass
scaffolds fabricated using the SLS process do
not possess enough structural strength for loadbearing applications and are suitable for non-load
bearing applications and, the scaffold stiffness
may not play a major role in bone regeneration.
Nevertheless, compressive modulus values of
all scaffold types are summarized in Table 3.
Although the values are significantly less than
the human trabecular bone elastic modulus (~10
GPa), the values are similar to or slightly lower
than that of a rat calvaria (1.5 – 4 GPa)[39-41].
Regression models have been proposed to
estimate the strength of a porous ceramic part
based on the void shape[42-45]. Duckworth first
proposed the exponential dependence of relative
strength using the equation below[44]:
88

Table 3. Compressive modulus of scaffolds at
designed porosities (in GPa).
Scaffold
Cubic
Spherical
X
Diamond
Gyroid

50
1.9±0.3
1.8±0.2
1.0±0.2
1.0±0.2
1.4±0.3

60
1.2±0.3
1.1±0.4
0.8±0.2
1.0±0.1
1.1±0.2

70
0.7±0.1
0.8±0.1
0.3±0.0
0.6±0.1
0.8±0.2

80
0.6±0.2
0.3±0.0
0.4±0.1

− BP
			 σ = σ oe 
(1)
where,
σ - Strength of porous part; σo - Strength of dense
part;
B - Empirical constant (pore shape factor);
p - Porosity fraction;

Mechanical properties of porous ceramic parts
are dependent on porosity and pore shape. The
results reported in the studies above showed that
the B value in the equation above varied between
5 and 9 for different ceramic materials and pore
shapes[43-46]. This model was adopted for structures
with basic pore shapes of oblate, elliptical, and
spherical[47]. Although the equation was developed
for nonrandom porous mullite ceramic parts,
it was reported that the compressive strength
of ceramic lattice structures fit the model with
independent modification of either the pore shape
or the pore size[46]. In our current study, scaffolds
had an open lattice structure and pores were highly

International Journal of Bioprinting (2020)–Volume 6, Issue 2

Kolan, et al.

interconnected, unlike the closed pores used in the
studies above. Hence, the compressive strength
variation with porosity did not fit well with
equation (1) and therefore, a slightly modified
version of equation (1) was used to fit the data by
introducing an additional empirical constant, A, as
given below:

other studies (B value varied between 5 and 9)[46,47].
For spherical scaffolds, A was <1 and B was <5.
To verify the applicability of this trend to scaffolds
made with other materials, silicate glass scaffolds
were fabricated with the same five architectures
and at similar porosity levels. Compressive
strength data for silicate glass scaffolds were fitted
to the model (R2 > 0.98) to obtain the following set
of equations for different architectures:

− BP
		 σ = Aσ oe 
(2)
where,
σ - Strength of lattice; σo - Strength of dense part;
A, B - Empirical constant; p - Porosity fraction;
Figure 3B shows the compressive strength
versus porosity data for all scaffolds with different
architectures fitted with the proposed model
(equation 2). The compressive strength (σo),
compressive modulus and density of the fully
dense parts (ϕ 5 mm cylinders; 6 mm in length)
were measured as 32.2 ± 6.4 MPa, 4.6 ± 0.8 GPa,
and 2.16 g/cc, respectively. The equations fitted
are given below:
σ = 3.9σ oe −6.3 p
Cubic scaffold:

X scaffold: 		

σ = 4.0σ oe −6.7 p

Gyroid scaffold:

σ = 1.1σ oe −6.0 p

−3.1 p
Spherical scaffold: σ = 0.6σ 0e
−8.6 p
Diamond scaffold: σ = 2.2σ oe

σ = 1.3σ oe −7.5 p
X scaffold:		
The silicate glass strength, modulus, and
density of the fully dense parts were 84.34 ± 5.95
MPa, 5.47 ± 1.05 GPa, and 2.3 g/cc, respectively.
As can be seen from the fitted equations for
silicate glass scaffolds, A was <1 and B was <5 for
spherical scaffold, while A was >1 and B varied
between 5 and 9 for the remaining scaffolds. This
behavior of spherical scaffolds was consistent for
borate glass and silicate glass scaffolds. In the
formulation of equation (2), it was assumed that
the empirical constants, A and B, in the model
could be functions of not only the pore shape
but also the pore shape variation with porosity.
For cubic, X, gyroid, and diamond unit cells, the

σ = 1.4σ oe −6.6 p

Spherical scaffold: σ = 0.7σ oe −2.7 p
−6.5 p
Gyroid scaffold: σ = 2.9σ oe
−5.3 p
Diamond scaffold: σ = 1.3σ 0e
With the exception of the spherical scaffold, A
value was >1 for all scaffolds and B value varied
between 5.3 and 6.6 and were in agreement with

A

Cubic scaffold:

B

Figure 3. Compression test results: (A) Compressive strength of borate glass scaffolds with five
architectures at different porosity levels. Vertical and horizontal error bars represent the standard
deviations of measured compressive strength and porosities, respectively, (B) curve fitting of strength
versus porosity fraction with R2 value for all curves is >0.98.
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overall pore shape remained relatively constant
with increasing porosity. However, for spherical
unit cell, pore shape at higher porosity (60%)
is different from pore shape at lower porosity
(30%). The variation of pore shapes of cubic and
spherical architectures is shown in Figure 2B. To
enable fabrication of spherical scaffolds at lower
porosities, the unit cell design was modified to
include cylindrical extensions to maintain the
pore size resulting in pore shape variation for the
spherical unit cell (Figure 2B). This variation in
pore shape could be the reason for the different
ranges of A and B values for spherical scaffolds
in comparison to the remaining four architectures.
To validate the above model, the data point at 32%
porosity for spherical scaffolds was excluded and
the remaining data for silicate glass scaffolds were
fitted with the model. Following this, the A value
was 1.4 and the B value was 5.0, which indicated
model agreement. This suggests that empirical
constants, A and B, could represent the pore shape
variation in addition to the pore shape and porosity.
3.3 Scaffold degradation in SBF
The scaffolds were mechanically tested in their
wet state after immersion in SBF for 1 week. The
compressive strength measured for most scaffolds
was about 3 MPa or less, which is near the low end
of the range of compressive strength (~2 – ~12 MPa)
of human trabecular bone[29]. The only exception to
this was spherical scaffolds at 32% porosity, which
A

had a compressive strength of ~4 MPa. A significant
reduction in compressive modulus values for all
scaffolds was also observed after 1 week, soaking
in SBF. Cubic scaffolds had the highest compressive
modulus ranging from 1.2 to 0.2 GPa, and X scaffolds
had the lowest modulus ranging from 190 to 52 MPa,
after soaking in SBF for 1 week. Figure 4A shows
scaffold compressive strengths of all scaffold types
and Figure 4C shows typical borate glass scaffold
transformation after soaking. Figure 4B shows the
percentage reduction in the compressive strength of
scaffold types at lower (<35%) and higher (>55%)
porosities. For high porosity, there was over a 90%
decrease in scaffold strength, irrespective of the
scaffold architecture. At low porosities, there was
at least a 50% strength reduction for all scaffold
regardless of their architecture. Among all scaffold
types, diamond scaffolds showed a strength reduction
that was consistently >80%, irrespective of the
scaffold porosity. The percentage strength reduction
varied from 80% to 92% for diamond scaffolds and
from 76% to 94% for X scaffolds. These two scaffold
architectures showed the largest strength reduction at
all porosities.
SEM images were analyzed for any crystallike formations on the bioactive glass surfaces
that typically appear after immersion in SBF.
Figure 5 shows SEM images of a representative
X architecture scaffold taken out of SBF after
1 week. The outer surface morphology of borate
and silicate glass scaffolds at lower magnification
is shown in Figures 5A and C, respectively. The

B

C

Figure 4. (A) Compressive strength of soaked scaffolds after 1 week in simulated body fluids (SBF), (B)
comparison of percentage strength reduction for scaffolds with different architectures at lower and higher
porosities, (C) optical image showing the physical transformation of the scaffold surface after soaking in
SBF for 1 week.
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corresponding higher magnification images are
shown in Figures 5B and D. These images show
the rounded spheroid-like formations on the borate
glass scaffold surface, unlike needle-like crystal
formations on silicate glass scaffold surface, similar
to observations made by other researchers with these
glasses[5,35]. The needle-like formations on silicate
glass surface were confirmed as crystalline HA using
XRD, whereas spheroid-like formations on borate
glass surface were not confirmed to any known
crystalline formations. This behavior of borate glass
is not uncommon as it was reported earlier that it
could take more than 60 days to form a crystalline
calcium phosphate layer in SBF and it also depends
on the strut size[48,49]. This was also observed in
some previous work which found the presence of
Ca2+ and PO34- on the reacted surface of the borate
glass, indicating an amorphous calcium phosphate
or carbonate-substituted apatite formation[50,51].
The degradation of scaffolds made with
resorbable materials depends on the material
composition and porosity. Scaffold degradation is
related to its surface area and the type of soaking
solution (SBF in this study). Scaffolds with higher
porosity degraded the most (~90% strength reduction
A

B

in 1 week) irrespective of architecture. This was
due to the higher surface area per unit volume and
large pores, all measuring about ~1 mm (Table 1),
that increased the efficiency of the ionic exchange
with SBF and made the degradation process more
rapid. To comprehend the trends in scaffolds with
lower porosities, the unit cell surface area of each
architecture (based on the CAD model) was plotted
against the percentage strength reduction, as shown
in Figure 6. Overall, the plot indicated a higher
strength reduction with increasing surface area to
volume ratio (SA/V). The SA/V data points for
gyroid and diamond scaffolds form a distinguishable
group from cubic, spherical, and X scaffolds.
However, for a given SA/V ratio (for example, SA/V
ratio of 2), diamond scaffolds show higher strength
reduction in comparison to cubic and spherical
scaffolds despite having a similar porosity. This
indicates that the lattice structure and pore geometry
do play an important role in controlling scaffold
degradation, especially in the case of scaffolds
made with bioresorbable materials such as bioactive
glasses. Moreover, it should be noted that the actual
SA/V values would be higher than the CAD values
because of the surface roughness that is inherent to
parts fabricated using the SLS process.
3.4 New bone formation
Scaffolds were firmly integrated with the
surrounding bone and pores were filled with

C

D

Figure 5. Scanning electron microscopy images of
borate glass and silicate glass scaffolds at low and
high magnifications after immersion in simulated
body fluids for 1 week: (A and B) Borate glass
outer surface morphology and rounded, irregular
spheroid-like formations, (C and D) silicate glass
scaffold surface and well defined needle-like
crystalline structures at higher magnification.

Figure 6. Percentage reduction in compressive
strength of a scaffold versus the ratio of total
surface area to volume of different architectures.
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formed in defects treated with cubic and diamond
scaffolds as a percentage of the total defect area
was 5.8 ± 1.0% and 6.2 ± 1.7%, respectively
(Figures 7A-D and 8). In contrast, a significant
amount of new bone tissue formation was observed
in defects treated with cubic and diamond scaffolds
loaded with BMP-2 (Figures 7E-H and 8). New
bone tissue formed in defects implanted with
cubic and diamond scaffolds occupied 39.9 ±
15.1% and 37.1 ± 13.8% of the total defect area,
respectively. After normalization based on the
scaffold porosities, the percentage of new bone
tissue formed in cubic and diamond scaffolds was
~74% and ~79%, respectively. Despite the higher
normalized bone formation in diamond scaffolds,
the result was not statistically significant (P = 0.8).
Magnified images of the H&E stained sections of
defects treated with borate glass scaffolds (cubic and
diamond) without BMP-2 are shown in Figure 9.

fibrous tissue with osteoblasts lining the poreglass interface. Figure 7 shows H&E stained
and Masson’s trichrome stained sections of fullthickness rat calvarial defect regions implanted
with cubic and diamond scaffolds for 6 weeks
with or without the presence of BMP-2. Although
scaffolds designed at 70% porosity were planned for
implantation, the apparent porosities of scaffolds
used were ~54% (cubic) and ~47% (diamond) with
an average pore size of 1 mm for both scaffold
types. The defects treated with cubic and diamond
scaffolds without BMP-2 (Figures 7A-D) showed
no significant in new bone formation. However,
small isolated pockets of new bone tissue formed
inside some defects and approximately 6% of the
total defect area was new bone tissue, including at
the outer edges and the bottom of the defect. No
statistical differences existed between scaffold
types. The average overall new bone tissue
A

B

C

D

E

F

G

H

Figure 7. Hematoxylin and eosin stained sections (left) and Masson’s trichrome stained sections (right)
of calvarial defect regions with four different treatment groups: (A) Cubic scaffolds without bone
morphogenetic protein 2 (BMP-2), (B) Cubic (left) and Diamond (right) scaffolds without BMP-2,
(C and D) diamond scaffolds without BMP-2, (E and F) cubic scaffolds with BMP-2, and (G and H)
diamond scaffolds with BMP-2. The arrows in the pictures point to the borders of the defect region. Dense
color (pink in H&E and blue in trichrome) in sections indicates mineralized bone tissue, white/background
color indicates remaining scaffold in the defect region. Red/maroon color in trichrome stained sections
indicates new bone. There was no significant new bone tissue formation in defects treated with scaffolds
without BMP-2. Defects treated with “scaffolds and BMP-2” show significant new bone formation. The
difference in tissue formation between cubic and diamond scaffolds even with BMP-2 was not significant.
92

International Journal of Bioprinting (2020)–Volume 6, Issue 2

Kolan, et al.

Figure 8. Percentage of new bone tissue
formation in cubic and diamond scaffolds
quantified based on the total defect area. The
bone growth between scaffold designs with or
without bone morphogenetic protein 2 (BMP-2)
was not statistically different. The bone formation
in defects treated with BMP-2 was statistically
significant (P = 0).
Figures 9A and B show the tissue formation inside
the diamond and cubic pores. In both cases, new
bone tissue formation can be observed at the edges
of the defect and in pores that are present on the
underside of the defect (just above dura matter), as
shown in the inset images. In addition, more mature
dense fibrous tissue was formed in diamond pores
in comparison to cubic pores (Figures 9C and D).
There was a high density of osteoblasts lining the
diamond scaffold surface, seen as dark purple stained
cells, and indicated by arrows in Figure 9A.
However, this was not apparent in cubic scaffolds
(Figure 9B). Magnified images of the osteoblasts
lining the scaffold surface, newly formed bone tissue,
and fibroblasts in the connective tissue are shown in
Figures 9C and D. Qualitative assessment of H&E
stained sections and trichrome stained sections
indicated a higher fibrous connective tissue in the
diamond pores in comparison to the cubic pores.
Figures 9E and F show new mineralized bone in
pores and dense connective tissue yet to become
bone. The presence of dense connective tissue and
marrow-like pockets in those regions indicates the
presence of endothelial cells which enable blood
vessel formation and new bone tissue formation.
Longer treatment duration (>6 weeks) could have
resulted in significantly higher bone formation in

A

B

C

D

E

F

Figure 9. Histological sections of defect regions
treated without bone morphogenetic protein 2
after 6 weeks. (A) Hematoxylin and eosin (H&E)
stained sections of diamond scaffold, (B) H&E
stained sections of cubic scaffold with the inset
figures showing fibrous tissue in the pores and
arrows indicating osteoblast cells lining the edges
of the diamond glass scaffold strut, (C and D)
magnified images of different regions of diamond
scaffold showing fibrous connective tissue,
newly formed bone tissue, and remaining glass,
(E) Masson’s trichrome stain showing pocket of
mineralized bone tissue in the pore and the new
bone tissue (red) surrounding the glass filament
indicated by dotted arrow, (F) Trichrome stain
showing mineralized bone tissue formed adjacent
to host bone tissue and from the bottom side of the
defect (above dura matter). N – new mineralized
bone, O – original host bone, G – remaining glass,
F – fibrous connective tissue.
diamond scaffolds in comparison to cubic scaffolds
based on the maturity of the fibrous tissue.
Our results showed significant new bone
formation in scaffolds treated with BMP-2.
Uncontrolled release or high doses of BMP-2
can result in negative consequences, including
tumor formation and undesired bone growth in
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soft tissue[52,53]. As expected, addition of BMP-2
significantly increased new bone formation to
almost 40%, based on the total defect area, and
almost filled the entirety of the pores. Our results
are consistent with a recent study that showed the
addition of BMP-2 at the same concentration (1 µg
per defect) to defects treated with HA microspheres
for the same time frame also created approximately
40% new bone in a 4.6 mm diameter rat calvarial
defect[54]. The above study investigated the role
of relaxin, a pregnancy hormone, to control and
enhance BMP-2 release to reduce the need for
high concentrations of BMP-2. It was reported
that the addition of 0.05 µg of relaxin to 0.5 µg of
BMP-2 induced higher bone formation compared
to 1 µg of BMP-2 alone per defect. In the future, a
combination of relaxin and BMP-2 together with
biomimetic architecture (such as diamond) could
further enhance bone regeneration and repair.
As new bone formation was about 6% for
both scaffold types without BMP-2, the results
obtained in this study are largely in agreement
with in vivo assessments using borate-based
bioactive glasses by other researchers. Table 4
concisely summarizes in vivo results using doped
and undoped borate glasses. The implantation time
for most studies was 8 or 12 weeks, though one
study had a 6-week time point to evaluate the bone
growth in defect regions using material extrusion

3D-printed scaffolds and reported approximately
6% new bone formation[55]. The material extrusion
3D-printed scaffolds had pores in the range 150 –
300 µm unlike the 1 mm pores of the cubic and
diamond scaffolds used in this study. Other studies
mentioned in Table 4 utilized scaffolds made with
polymer foam replication technique, freeze-drying
technique, and pressed short fiber technique that
have significantly smaller pore sizes, thinner strut
diameters, and higher porosities. The amount
of bone formation in terms of defect region was
reported in the range of 9 – 28% after 12 weeks
of implantation. A relatively higher amount of
bone formation (up to 30%) was reported when
scaffolds were made with copper and zinc doped
borate glass. Higher bone growth for all the above
scaffolds could be due to smaller pore size range
and higher porosities compared to the scaffolds
used in this study, which were limited by the laser
spot size of the SLS process. The role of pore size
is not completely understood as there exist reports
with mixed results when using scaffolds with a
range of pore sizes for bone regeneration[28]. While
some studies have reported that average pore sizes
in the range of 100 – 300 µm are effective for bone
tissue growth, others have suggested large pores
in the range of 600 –1000 µm are better for tissue
growth[56,57]. Another study suggested a nonlinear
effect of pore size on bone tissue regeneration for

Table 4. In vivo assessment of borate-based bioactive glasses for bone regeneration.
Study

Scaffold type

Gu et al.[55,58]

3D-printed gridlike and pressed
short fibers

Bi et al.[30]
Bi et al.[59]

Pressed short fibers Φ4.6 mm rat cranial – 12 weeks
3D-printed grid6 mm femur
like and freeze
12 weeks
drying

Wang et al.[60,61]

Polymer foam
replication

Φ5.0 mm rat cranial – 8 weeks

This study

SLS

Φ4.6 mm rat cranial – 6 weeks

94

Defect and treatment duration

Porosity (%) and
pore size (µm)
Φ4.6 mm rat cranial – 6 and 12 weeks 47 and 150 – 300
(grid-like)
58 and 50 – 550
(pressed fibers)
58 and 50 – 500
50 and 140 – 250
(grid-like)
47 and 50 – 150
(freeze drying)
80 – 89 and 200
– 400
47 – 54 and 1000
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New bone
formation
Grid-like
6% (6 weeks)
9% (12 weeks)
pressed fibers
20% (12 weeks)
15%
26% (grid-like) and
28% (freeze drying)
16% (undoped)
29% (Zn doped)
30% (Cu coped)
6% (no BMP-2)
40% (BMP-2)
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polymer scaffolds with 100 – 300 µm pores having
an accelerated effect during the first 4 weeks which
quickly fell off after 8 weeks of implantation[27]. If
that was the case, grid-like borate glass scaffolds
with 150 – 300 µm pores should have higher bone
formation within 6 weeks in comparison to SLS
scaffolds with 1 mm pore size used in this study.
Since this was not observed, nonlinear effects
of pore sizes on bone regeneration might not be
the case for bioresorbable material scaffolds. The
qualitative comparison of H&E stains reported in
other in vivo studies (Table 4) showed that bone
formation was mainly through the infiltration of
fibrous tissue and initiated from the dura mater side
of the scaffold. This is in strong agreement with
our study. In addition, the quantification of bone
growth as 6% in our study compared to 15% in
other studies could be subject to a large deviation.
In our previous study, diamond and gyroid
architecture scaffolds made with silicate glass
showed significant cell proliferation in vitro in
comparison to cubic scaffolds[34]. Nevertheless,
a significant difference in in vivo bone growth
for diamond scaffolds versus cubic scaffolds
was not observed in the current study. However,
qualitative analysis indicated a more mature
fibrous tissue in defects treated with diamond
scaffolds. While the fibrous tissue in the diamond
scaffold appears to have osteocytes, indicating
that it has almost transformed into new bone,
while the fibrous tissue from the central region of
the cubic scaffold appears to be soft tissue. This
indicates that it would take longer to form new
bone within the cubic scaffold in comparison to
the diamond scaffold. Faster maturation of fibrous
tissue in the diamond scaffold could be attributed
to the curvature that drives the fibrous tissue, and
thereby osteoblasts and osteocytes, to orient and
adapt to the pore geometry. A scaffold’s mechanical
properties are known to influence cell proliferation,
differentiation, and bone regeneration[62].
However, the mechanical properties could not
be a major factor in a calvarial defect model
because it is not for load-bearing application, and
studies showed no apparent correlation between
scaffold compressive modulus, strength, and
bone formation (Table 4). It is likely that scaffold

material (e.g. silicate glass, borate glass, or HA),
pore size, porosity, and architecture play a more
important role than strength and modulus in a
calvarial defect model. Moreover, there was no
significant difference in compressive strength
and modulus of cubic (4.3 MPa and 0.7 GPa) and
diamond (3.5 MPa and 0.6 GPa) scaffolds used
for in vivo assessment in this study. Therefore, the
difference in bone and fibrous tissue formation is
more likely due to architecture.
This study demonstrated the fabrication of
biomimetic borate glass scaffolds using the SLS
process. The faster degradation of borate glass
scaffolds was likely because of the increased
surface area associated with the SLS part surface
roughness. After immersion in SBF for 1 week,
SLS borate glass scaffolds showed a 60% –
90% reduction in strength, depending on the
architecture. This data provide an opportunity to
design an implant to repair defect sites based on
the strength requirements of the skeletal region.
This shows the potential of the laser powder
bed fusion process for bone repair by utilizing a
combination of architecture, porosity, and choice
of bioactive glass for scaffold fabrication. For
example, diamond architecture could be the
choice for an implant fabricated with a bioactive
glass having a slower degradation rate (such as
silicate glass) as diamond scaffolds degrade faster
and have the potential to provide more bone
regeneration in vivo. In a similar fashion, if high
structural integrity is needed for tissue repair in a
load-bearing bone, a lower porosity design using
a cubic or spherical architecture could be the best
option to slow down degradation. The laser powder
bed fusion process can be used to manufacture
bioactive glass scaffolds for bone repair with
controlled degradation by selecting the appropriate
geometric design and material combinations.
4 Conclusions
Borate-based bioactive glass scaffolds with
different porosities and pore sizes were fabricated
using the SLS process, with scaffold porosities
varying from 30% to 60% and pore sizes varying
from 0.5 to 1.2 mm. Scaffold strength and
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degradation in vitro are dependent on porosity and
architecture. Among the five different architectures
considered in this study (cubic, spherical, x,
gyroid, and diamond), cubic scaffolds provided the
highest compressive strength (16 MPa) at lower
porosities (<35%) and spherical scaffolds had
the highest strength (4 MPa) at higher porosities
(>60%). Gyroid and diamond scaffolds recorded
greater strength reduction after 1-week immersion
in SBF, likely because of their biomimetic
architectures mimicking natural bone. This study
has shown that powder bed fusion processes can
be used to fabricate scaffolds with controlled rates
of strength degradation and bone regeneration by
selecting appropriate architecture and bioactive
glass composition. These scaffolds can be used to
repair specific regions of trabecular bone, based
on functional requirements. Cubic and diamond
scaffolds with ~50% porosity and ~1 mm pore
size were used to treat a full-thickness 4.6 mm
diameter rat calvarial defect with or without
BMP-2. There was no significant difference in
mineralized bone formation for defects treated
with cubic and diamond architectures after 6 weeks
of implantation. However, a higher percentage
of fibrous connective tissue and high osteoblast
activity was observed in the defects treated
with diamond scaffolds. The addition of BMP-2
significantly increased the bone regeneration from
6% (without BMP-2) to 40% of the defect area.
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